...
首页> 外文期刊>Current cardiology reports. >Ultrasound- and Microspheres-Enhanced Thrombolysis for Stroke Treatment: State of the Art
【24h】

Ultrasound- and Microspheres-Enhanced Thrombolysis for Stroke Treatment: State of the Art

机译:超声和微球增强溶栓治疗中风:最新技术

获取原文
获取原文并翻译 | 示例
           

摘要

Intravenous administration of recombinant tissue-plasminogen activator (rt-PA) remains the fastest and widely feasible strategy to initiate treatment in acute ischemic stroke. Because it works by inducing recanalization of an occluded vessel, augmentation of this process is desirable and diagnostic transcranial Doppler (TCD) ultrasound can accomplish this safely. A 2-MHz pulsed-wave monitoring can at least double the chance of early complete arterial recanalization at no increase in the risk of symptomatic intracerebral hemorrhage. Gaseous microspheres, initially developed as ultrasound contrast agents, can further increase the effectiveness of rt-PA. A recent microsphere dose-escalation study called TUCSON showed sustained complete recanalization rates of 67% in patients receiving TCD monitoring with a 1.4-mL perflutren-lipid microsphere dose compared with controls receiving rt-PA alone with no increase in hemorrhage rate. In this article, we review the current and emerging applications of ultrasound and microspheres in stroke management including augmentation of systemic thrombolysis and implications for future reperfusion strategies.
机译:静脉内注射重组组织纤溶酶原激活物(rt-PA)仍然是在急性缺血性中风中开始治疗的最快且广泛可行的策略。因为它通过诱导闭塞的血管再通而起作用,所以需要扩大该过程,而诊断性经颅多普勒(TCD)超声可以安全地完成此过程。在不增加症状性脑出血风险的情况下,使用2 MHz脉冲波监测至少可以使早期完全动脉再通的机会增加一倍。最初被开发为超声造影剂的气态微球可以进一步提高rt-PA的有效性。最近一项名为TUCSON的微球剂量递增研究显示,与仅接受rt-PA的对照组相比,接受1.4-mL氟哌啶脂微球剂量接受TCD监测的患者持续完全再通率达到67%。在本文中,我们回顾了超声和微球在卒中管理中的当前和新兴应用,包括增强系统溶栓作用及其对未来再灌注策略的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号